PRECLINICAL STUDIES ON HUNTINGTON'S DISEASE
Move your Huntington’s pipeline forward with PharmaLegacy’s extensively validated models.
PHARMALEGACY HAS THE EXPERTISE AND MODELS YOU NEED TO ADVANCE YOUR HUNTINGTON’S DISEASE PROGRAM.
MODELS / SERVICES
The PharmaLegacy advantage:
- We initiate most studies in under 2 weeks
- Capacity for 200+ concurrent studies
- Scientific staff with 15+ years of experience on average
- 1500+ validated animal models of disease spanning 100+ indications
See why 18 of the top 20 pharmaceutical companies trust PharmaLegacy. Contact us today.
We’re ready when you are.
Tell us your Huntington’s pipeline challenges.
